Circulating miRNAs as Potential Biomarkers of Age-Related Macular Degeneration

被引:53
作者
Ren, Chengda [1 ]
Liu, Qingyu [1 ]
Wei, Qingquan [2 ]
Cai, Wenting [1 ]
He, Mengmei [1 ]
Du, Yaru [3 ]
Xu, Ding [1 ]
Wu, Yan [4 ]
Yu, Jing [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai, Peoples R China
[2] Nanchang Univ, Shanghai Peoples Hosp 10, Dept Ophthalmol, Nanchang, Jiangxi, Peoples R China
[3] Nanjing Med Univ, Dept Clin Med Coll 1, Shanghai Peoples Hosp 10, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China
[4] Soochow Univ, Affiliated Hosp 1, Dept Ophthalmol, Suzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Age-related macular degeneration; microRNA; Microarray; Diagnosis; Case-control; PIGMENT EPITHELIAL-CELLS; COLORECTAL-CANCER; AMD; PLASMA; COMPLEMENT; MICRORNAS;
D O I
10.1159/000467941
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Backgroud: Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness of the elder people. This research was intended to demonstrate the different expression of microRNAs (miRNA) in AMD patients and whether they can be used as biomarkers for AMD. Methods: MiRNAs expression was measured by microarray of 6 AMD cases and 6 gender matched controls. In a larger-sample case-control study with 126 AMD cases and 140 controls, whole blood samples were detected for the differences of miRNA expression. Results: A total of 216 differentially expressed miRNAs (111 increased and 105 decreased miRNAs) were detected from circulating miRNA microarray. Expanded case-control study results showed that the expression of miR-27a-3p, miR-29b-3p and miR-195-5p was increased significantly. Moreover, the level of miR-27a is higher in patients with wet AMD compared to patients with dry AMD. All 3 miRNAs showed a potential diagnostic value for AMD. Conclusion: Circulating miRNA levels were significantly varied in AMD patients. Three miRNAs, miR-27a-3p, miR-29b-3p and the miR-195-5p, might be potential diagnostic biomarkers for AMD. (C) 2017 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1413 / 1423
页数:11
相关论文
共 28 条
[1]   MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer [J].
Armstrong, David A. ;
Green, Benjamin B. ;
Seigne, John D. ;
Schned, Alan R. ;
Marsit, Carmen J. .
MOLECULAR CANCER, 2015, 14
[2]   microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration [J].
Bhattacharjee, Surjyadipta ;
Zhao, Yuhai ;
Dua, Prerna ;
Rogaev, Evgeny I. ;
Lukiw, Walter J. .
PLOS ONE, 2016, 11 (03)
[3]   Age-related macular degeneration: Complement in action [J].
Campagne, Menno van Lookeren ;
Strauss, Erich C. ;
Yaspan, Brian L. .
IMMUNOBIOLOGY, 2016, 221 (06) :733-739
[4]   Aβ-Induced Senescent Retinal Pigment Epithelial Cells Create a Proinflammatory Microenvironment in AMD [J].
Cao, Lining ;
Wang, Hao ;
Wang, Fang ;
Xu, Ding ;
Liu, Fang ;
Liu, Chaoqi .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (05) :3738-3750
[5]   MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection [J].
Chang, Pi-Yueh ;
Chen, Chia-Chun ;
Chang, Yu-Sun ;
Tsai, Wen-Sy ;
You, Jeng-Fu ;
Lin, Geng-Ping ;
Chen, Ting-Wen ;
Chen, Jinn-Shiun ;
Chan, Err-Cheng .
ONCOTARGET, 2016, 7 (09) :10663-10675
[6]   MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice [J].
Chen, Hai-Yong ;
Zhong, Xiang ;
Huang, Xiao R. ;
Meng, Xiao-Ming ;
You, Yongke ;
Chung, Arthur C. K. ;
Lan, Hui Y. .
MOLECULAR THERAPY, 2014, 22 (04) :842-853
[7]   MicroRNA-23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis [J].
Chen, Q. ;
Xu, J. ;
Li, L. ;
Li, H. ;
Mao, S. ;
Zhang, F. ;
Zen, K. ;
Zhang, C-Y ;
Zhang, Q. .
CELL DEATH & DISEASE, 2014, 5 :e1132-e1132
[8]  
Chen XJ, 2015, ONCOTARGET, V6, P37553, DOI 10.18632/oncotarget.6065
[9]   Treatment for neovascularage related macular degeneration: The state of the art [J].
Eandi, Chiara M. ;
Alovisi, Camilla ;
De Sanctis, Ugo ;
Grignolo, Federico M. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 787 :78-83
[10]  
Ertekin S, 2014, MOL VIS, V20, P1057